DUSA PHARMACEUTICALS INC (NASDAQ: DUSA)

View Portfolio
Back to Investopedia
Back to Investopedia




$1.40 0.04 (2.94%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
1.87
52-Week Low Price
0.88
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.03 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.26
Shares
24.11 M
Dividend Rate ($) / (%)
0.00/0.00
65%
35%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 14% - DUSA has underperformed the S&P 500 by 12%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
CNS RESPONSE INC (CNSO) $0.65 -  $0.00(0.00%)0.03 B
HESKA CORPORATION (HSKA) $0.64 -  $0.02(3.05%)0.03 B
MABCURE INC (MBCI) $0.52 -  $0.00(0.00%)0.03 B
MOLECULAR INSIGHT PHARMA (MIPI) $1.23 -  $0.02(1.61%)0.03 B
NILE THERAPEUTICS INC (NLTX) $1.24 -  $0.18(16.98%)0.03 B
MEDICAL NUTRITION USA (MDNU) $1.95 -  $0.25(11.36%)0.03 B
AMARIN CORP PLC ADS (AMRN) $1.06 -  $0.03(2.75%)0.03 B
SUNESIS PHARMACEUTICALS (SNSS) $0.83 -  $0.02(1.99%)0.03 B
QUIGLEY CORP THE (QGLY) $2.09 -  $0.00(0.00%)0.03 B
CARDIOVASCULAR BIOTHER... (CVBT) $0.17 -  $0.00(2.94%)0.03 B
As of February 09, 2010 at 1:50 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
DUSA RELATED HEADLINES
arrow
BRIEF-DUSA Pharmaceuticals Q4 results

Forbes.com 3/11/2009
arrow
BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX

Forbes.com 7/25/2008
arrow
Dusa Pharmaceuticals files shelf registration

Forbes.com 5/16/2008
arrow
Biotech CEOs list potential
Exclusive news from the Roth Conference featuring a video clip and notes of CEO presentations
Wall Street Media 2/20/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1